Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.

Dasgupta A, Khan A, Banerjee U, Ghosh M, Pal M, Chowdhury KM, Dasgupta S.

Indian J Clin Biochem. 2013 Apr;28(2):169-76. doi: 10.1007/s12291-012-0253-4. Epub 2012 Sep 14.

PMID:
24426204
[PubMed]
Free PMC Article
2.

[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].

Li X, Lin JF.

Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71. Chinese.

PMID:
16409817
[PubMed - indexed for MEDLINE]
3.

[Exploration of the classification of polycystic ovarian syndrome].

Lin JF, Li X, Zhu MW.

Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Chinese.

PMID:
17199924
[PubMed - indexed for MEDLINE]
4.

Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.

Pehlivanov B, Mitkov M.

Eur J Contracept Reprod Health Care. 2009 Apr;14(2):153-9. doi: 10.1080/13625180802549962.

PMID:
19340711
[PubMed - indexed for MEDLINE]
5.

[Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].

Li Y, Wei LN, Xiong YL, Liang XY.

Zhonghua Fu Chan Ke Za Zhi. 2010 Aug;45(8):567-70. Chinese.

PMID:
21029609
[PubMed - indexed for MEDLINE]
6.

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.

Clin Endocrinol (Oxf). 2004 Dec;61(6):738-46.

PMID:
15579189
[PubMed - indexed for MEDLINE]
7.

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.

Sieminska L, Marek B, Kos-Kudla B, Niedziolka D, Kajdaniuk D, Nowak M, Glogowska-Szelag J.

J Endocrinol Invest. 2004 Jun;27(6):528-34.

PMID:
15717649
[PubMed - indexed for MEDLINE]
8.

Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.

Singh S, Akhtar N, Ahmad J.

Diabetes Metab Syndr. 2012 Oct-Dec;6(4):207-11. doi: 10.1016/j.dsx.2012.05.013. Epub 2012 Jul 6.

PMID:
23199540
[PubMed - indexed for MEDLINE]
9.

High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.

Verit FF.

Arch Gynecol Obstet. 2010 Jun;281(6):1009-14. doi: 10.1007/s00404-009-1226-6. Epub 2009 Sep 22.

PMID:
19771438
[PubMed - indexed for MEDLINE]
10.

Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.

Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB.

J Adolesc Health. 2010 May;46(5):474-81. doi: 10.1016/j.jadohealth.2009.10.008. Epub 2010 Jan 4.

PMID:
20413084
[PubMed - indexed for MEDLINE]
11.

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.

Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.

PMID:
18063948
[PubMed - indexed for MEDLINE]
12.
13.

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.

Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N.

Clin Endocrinol (Oxf). 2001 Apr;54(4):447-53.

PMID:
11318779
[PubMed - indexed for MEDLINE]
14.
15.

Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

Pangaribuan B, Yusuf I, Mansyur M, Wijaya A.

Ther Adv Endocrinol Metab. 2011 Dec;2(6):235-45. doi: 10.1177/2042018811423770.

PMID:
23148188
[PubMed]
Free PMC Article
16.

Anthropometric parameters as indicators of metabolic derangements in schizophrenia patients stabilized on olanzapine in an Indian rural population.

Rout JK, Dasgupta A, Singh OP, Banerjee U, Das B.

J Neurosci Rural Pract. 2012 Sep;3(3):277-82. doi: 10.4103/0976-3147.102605.

PMID:
23188977
[PubMed]
Free PMC Article
17.

[Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].

Pekhlivanov B, Mitkov M, Orbtsova M, Terzieva D.

Akush Ginekol (Sofiia). 2008;47(3):15-9. Bulgarian.

PMID:
18756827
[PubMed - indexed for MEDLINE]
18.

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.

Wu J, Zhu Y, Jiang Y, Cao Y.

Gynecol Endocrinol. 2008 Jul;24(7):392-8. doi: 10.1080/09513590802217027.

PMID:
18608522
[PubMed - indexed for MEDLINE]
19.

Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.

Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.

Gynecol Endocrinol. 2007 Sep;23(9):505-10.

PMID:
17852421
[PubMed - indexed for MEDLINE]
20.

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.

Holte J, Bergh T, Gennarelli G, Wide L.

Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81.

PMID:
7955458
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk